Zinc concentrations in serum during head and neck cancer progression

Anticancer Research

Volumn 27, Issue 4 A, 2007, Pages 1941-1943

  Büntzel, Jens ^a,b   Bruns, Frank ^b,c   Glatzel, Michael ^a,b   Garayev, Asadulla ^a   Mücke, Ralph ^b,d   Kisters, Klaus ^b,e   Schäfer, Ulrich ^b,f   Schönekaes, Klaus ^b   Micke, Oliver ^b,g  

^a Sudharzkrankenhaus Nordhausen ^*  (Germany)

^b AKTE   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d ST JOSEFS HOSPITAL   (Germany)

^e ST ANNA HOSPITAL   (Germany)

^f KLINIKUM LIPPE DETMOLD   (Germany)

^g FRANZISKUS HOSPITAL   (Germany)

Author keywords

Head and neck cancer; Serum; Zinc

Indexed keywords

TUMOR MARKER; ZINC;

ADULT; AGED; CANCER GROWTH; CANCER STAGING; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; HYPOPHARYNX CANCER; LARYNX CANCER; MALE; OROPHARYNX CANCER; PRIORITY JOURNAL; ZINC BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SPECTROPHOTOMETRY, ATOMIC; TUMOR MARKERS, BIOLOGICAL; ZINC;

EID: 34250717309     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Bruns F, Mücke R and Büntzel J: Zink und Kupfer. In: Zytoprotektion, Spurenelemente und Elektrolyte in der Tumortherapie. Büntzel J, Kisters K, Mücke R, Micke O (eds.). Dustri, Munich, pp. 120-131, 2004.
2. Duncan JR and Dreosti IE: Zinc intake, neoplastic DNA synthesis, and chemical carcinogenesis in rats and mice. J Natl Cancer Inst 55: 195-196, 1975.
3. Jayadeep A, Raveendran Pillai K and Kannan S, Nalinakumari KR, Mathew B, Krishnan Nair M and Menon VP: Serum levels of copper, zinc, iron, and coeruloplasmin in oral leukoplakia and squamous cell carcinoma. J Exp Clin Cancer Res 16: 295-300, 1997.
4. Büntzel J, Glatzel M, Micke O and Fröhlich D: Status essentieller Spurenelemente bei unbehandelten Kopf-Hals-Karzinomen. Laryngo-Rhino-Otol 82: 573-577, 2003.
5. Büntzel J, Bruns F, Glatzel M, Mücke R, Micke O, Kisters K and Schönekaes KG: Kupfer und Zink im Serum von Patienten mit HNO-Karzinomen. In: Anke M, Flachowsky G, Kisters K, Schäfer U, Schenkel H, Seifert M, Stoeppler M (eds.): Macro and Trace Elements. 22nd Workshop, September 24th and 25th 2004. Schubert, Leipzig, pp. 944-947, 2004.
6. Becker N and Wahrendorf J: Atlas of Cancer Mortality in the Federal Republic of Germany 1981-1990, 3rd ed. Springer, Heidelberg, 1998.
7. Pich A, Chiusa L and Navone R: Prognostic relevance of cell proliferation in head and neck tumours. Ann Oncol 15: 1319-1329, 2004.
8. Büntzel J, Hornig A Glatzel M, Micke O, Bruns F, Schäfer U and Fröhlich D: Tumor markers and lymphatic metastasis in head and neck cancer patients. Anticancer Res 25: 1539-1542, 2005.
9. Micke O, Bruns F, Schäfer U, Horst E, Büntzel J and Willich N: The clinical value of squamous cell carcinoma antigen in patients irradiated for locally advanced cancer of the head and neck. Anticancer Res 23: 907-911, 2003.
10. Ceruse P, Rabilloud M, Charrie A, Dubreuil C and Disant F: Study of CYFRA 21-1, a tumour marker, in head and neck squamous cell carcinoma. Ann Otol Rhinol Laryngol 114: 768-776, 2005.